Tenders/Conclusion of Non-Exclusive Discount Agreements according to § 130a Para. 8 SGB V for the Active Ingredients Etanercept (ATC L04AB01) and Epoetin alfa/zeta (ATC B03XA01)

Open🇩🇪GermanySupplies

Conclusion of Non-Exclusive Discount Agreements according to § 130a Para. 8 SGB V for the Active Ingredients Etanercept (ATC L04AB01) and Epoetin alfa/zeta (ATC B03XA01)

Auto-translated from German

Original title: Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den Wirkstoffen Etanercept (ATC L04AB01) und Epoetin alfa/zeta (ATC B03XA01)

GWQ ServicePlus AG

Published: Oct 27, 2026

Updated: Oct 27, 2026

Source: DÖE Bekanntmachungsservice (Germany)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Germany, Europe, this opportunity is open to firms and consortiums.

Published through DÖE Bekanntmachungsservice (Germany), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: German

§ 130a Abs. 8 bzw. § 130c Abs. 8 SGB V ermöglicht den Krankenkassen (KK) und pharmazeutischen Unternehmen, Rahmenrabattverträge über die zu Lasten der gesetzlichen KK abzugebenden Arzneimittel zu schließen. Die GWQ wird als Gesellschaft für Wirtschaftlichkeit und Qualität bei KK gem. § 130a Abs. 8 S. 5 SGBV für ihre Aktionärs- und Kundenkassen tätig. In Hinblick auf die dafür einschlägigen gesetzlichen Vorschriften zur Vergabe öffentlicher Aufträge, findet ein regelmäßiger Prozess wirkstoffbezogener, förmlicher Vergabeverfahren nach den Regularien des 4. Teils des GWB durch die GWQ ServicePlus AG statt. Die GWQ geht davon aus, dass dieses Verfahren auf Grund einer fehlenden Auswahlentscheidung und mithin der diskriminierungsfreien Zugangsmöglichkeit aller pharmazeutischen Unternehmen nicht in den Anwendungsbereich des Kartellvergaberechts fällt. Die GWQ ServicePlus AG beabsichtigt, federführend für die Krankenkassen der ARGE-OH-Bio Tech, nicht-exklusive Rabattvereinbarungen nach § 130a Abs. 8 SGB V mit Vertragsstart zum 01.01.2027 zu schließen. Folgende Krankenkassen gehören der ARGE-OH-BioTech an: - DAK-Gesundheit - Techniker Krankenkasse - Kaufmännische Krankenkasse - HEK - Hanseatische Krankenkasse - hkk - Handelskrankenkasse - GWQ ServicePlus AG (bevollmächtigt für die in Anlage 3 genannten Krankenkassen).

Data provenance

This notice is sourced from DÖE Bekanntmachungsservice (Germany) and was originally published on October 27, 2026. Last refreshed today. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About GWQ ServicePlus AG

GWQ ServicePlus AG has issued 61 procurement notices on BidsFactory, including 26 currently open and 20 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU), DÖE Bekanntmachungsservice (Germany), and service.bund.de (Germany). Most recent publication: October 27, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit DÖE Bekanntmachungsservice (Germany) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by GWQ ServicePlus AG in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.